Fine Foods & Pharmaceuticals Ntm Logo

Fine Foods & Pharmaceuticals Ntm

FF | XMIL

Overview

Corporate Details

ISIN(s):
IT0005215329 (+1 more)
LEI:
8156009111DEE8553765
Country:
Italy
Address:
VIA BERLINO, 39 (ZINGONIA), 24040 VERDELLINO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Fine Foods & Pharmaceuticals NTM is an integrated Contract Development and Manufacturing Organization (CSDMO) specializing in oral solid forms. Founded in 1984, the company serves as a manufacturing partner for the pharmaceutical, nutraceutical (food supplements), cosmetic, and medical device industries. Its core services encompass the development and contract manufacturing of a wide range of products, including pharmaceuticals, supplements, cosmetics, and biocides. The company emphasizes scientific rigor, technological innovation, and a long-standing commitment to sustainability. With over 100 manufacturing lines and a significant portion of its workforce dedicated to science and R&D, Fine Foods aims to provide agile, high-quality manufacturing solutions to support its clients' growth objectives.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Fine Foods & Pharmaceuticals Ntm. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-02 14:17
Regulatory News Service
Allegato 3F / ANNEX 3F
Italian 28.6 KB
2025-08-25 13:01
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 18 AGOSTO – 22 AGOSTO 2025 / …
English 500.7 KB
2025-08-18 12:40
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 11 AGOSTO – 14 AGOSTO 2025 / …
Italian 482.1 KB
2025-08-08 12:38
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 4 AGOSTO – 7 AGOSTO 2025 / TR…
Italian 450.2 KB
2025-08-06 11:22
Report Publication Announcement
Publication Notice – Half-year Financial Report as of 30 June 2025
English 263.9 KB
2025-08-06 11:21
Report Publication Announcement
Avviso di pubblicazione della Relazione Finanziaria semestrale al 30 giugno 2025
Italian 275.2 KB
2025-08-06 11:16
Interim Report
Relazione finanziaria semestrale al 30 giugno 2025
Italian 3.5 MB
2025-08-05 14:29
Earnings Release
Growing revenue Adjusted EBITDA was €21.6 million, +35%, and margins for 16.8%
English 579.2 KB
2025-08-05 14:28
Earnings Release
Ricavi in crescita EBITDA Adj. a €21,6 milioni, +35%, e marginalità al 16,8%
Italian 535.2 KB
2025-08-04 16:05
Director's Dealing
Allegato 3F / Annex 3F
Italian 28.8 KB
2025-08-04 14:05
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 28 LUGLIO – 1 AGOSTO 2025 / T…
Italian 468.9 KB
2025-07-28 12:16
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 21 LUGLIO – 25 LUGLIO 2025 / T…
Italian 456.2 KB
2025-07-21 11:42
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 14 LUGLIO – 18 LUGLIO 2025 / …
Italian 449.9 KB
2025-07-14 10:59
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 7 LUGLIO – 11 LUGLIO 2025 / T…
Italian 430.0 KB
2025-07-07 11:48
Regulatory News Service
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 30 GIUGNO – 4 LUGLIO 2025 / TR…
Italian 455.8 KB

Automate Your Workflow. Get a real-time feed of all Fine Foods & Pharmaceuticals Ntm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fine Foods & Pharmaceuticals Ntm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK